Novel magnetic bimetallic AuCu catalyst for reduction of nitroarenes and degradation of organic dyes

Herein, core-shell magnetic nanoparticles are modified with imidazolium-tagged phosphine and propylene glycol moieties and used for the stabilization of bimetallic AuCu nanoparticles. The structure and morphology of the prepared material are identified with SEM, TEM, XRD, XPS, atomic absorption spectroscopy, Fourier translation infrared spectroscopy, and a vibrating sample magnetometer. This hydrophilic magnetic bimetallic catalyst is applied in the reduction of toxic nitroarenes and reductive degradation of hazardous organic dyes such as methyl orange (MO), methyl red (MR), and rhodamine B (RhB), as well as in the degradation of tetracycline (TC). This magnetic AuCu catalyst indicated superior activity in all three mentioned reactions in comparison with its single metal Au and Cu analogs. This catalyst is recycled for 17 consecutive runs in the reduction of 4-nitrophenol to 4-aminophenol without a significant decrease in catalytic activity and recycled catalyst is characterized.

Pd nanoparticles embedded in nanolignin (Pd@LNP) as a water dispersible catalytic nanoreactor for Cr(VI), 4-nitrophenol reduction and CC coupling reactions

The use of water-dispersible and sustainable Pd nanocatalysts to reduce toxic heavy metal ions and catalyze important organic reactions has profound significance for the environmental remediation and the catalytic industry. In this work, a novel water-dispersible and recyclable Pd@LNPs nanoreactor composed of Pd nanoparticle cluster core and LNPs shell was developed in microwave reactor in aqueous solution. It turned out that Pd nanoparticles grew uniformly and stably inside LNPs nanosphere due to the coordinated binding and interaction between Pd and the functional groups in LNPs, which was significantly different from surface loading. The green and biodegradable LNPs nanospheres are not only used as reducing agents for Pd (II) and nanocarriers, but also act as individual nanocontainers to provide favorable sites for reactions and effectively control the entry and release of reactants and products. Furthermore, the excellent and efficient catalytic properties of Pd@LNPs were exhibited by CC coupling reactions and the reduction of Cr(VI) and 4-nitrophenol. The Pd@LNPs prepared in this study have the advantages of excellent dispersion, great recyclability, high turnover frequency and better green sustainability metrics. It will have a great significance for the development of the potential high-value of lignin and the progress in the field of bio-nanocatalysts.

Inhibitory Effect of Topical Cartilage Acellular Matrix Suspension Treatment on Neovascularization in a Rabbit Corneal Model

BACKGROUND

The extracellular matrix (ECM) of articular cartilage has an inhibitory effect on vascularization, yet clinical utilization has been technically challenging. In this study, we aimed to fabricate a biologically functional ECM powder suspension from porcine articular cartilage that inhibits neovascularization (NV).

METHODS

The digested-cartilage acellular matrix (dg-CAM) was prepared by sequential processes of decellularization, enzymatic digestion and pulverization. Physicochemical properties of dg-CAM were compared with that of native cartilage tissue (NCT). Cellular interactions between human umbilical vein endothelial cells (HUVECs) and dg-CAM was evaluated with proliferation, migration and tube formation assays compared with that of type I collagen (COL) and bevacizumab, an anti-angiogenic drug. We then investigated the therapeutic potential of topical administration of dg-CAM suspension on the experimentally induced rabbit corneal NV model.

RESULTS

The dg-CAM released a significantly larger amount of soluble proteins than that of the NCT and showed an improved hydrophilic and dispersion properties. In contrast, the dg-CAM contained a large amount of collagen, glycosaminoglycans and anti-angiogenic molecules as much as the NCT. The inhibitory effect on NV of the dg-CAM was more prominent than that of COL and even comparable to that of bevacizumab in inhibiting the HUVECs. The therapeutic potential of the dg-CAM was comparable to that of bevacizumab in the rabbit corneal NV model by efficiently inhibiting neovessel formation of the injured cornea.

CONCLUSION

The current study developed a dg-CAM having anti-angiogenic properties, together with water-dispersible properties suitable for topical or minimally invasive application for prevention of vessel invasion.